It wasn't that long ago that the only way to test for Alzheimer's disease was to perform an autopsy on someone who had been ...

A new study from Auburn University provides new insights into neuronal connections, offering hope for the treatment of ...

Table of Contents Transforming Treatment Approaches From Lab Discovery to Clinical Impact Paper Summary In a nutshell A new ...

Manufacturers of Alzheimer’s disease drugs have identified blood tests as a way to accelerate diagnosis and treatment.

The blood test for eMTBR-tau243 shows strong correlation with tau pathology, enhancing Alzheimer's diagnosis and monitoring ...

For decades, the gold standard for diagnosing Alzheimer's disease revolved around examining the brain post-mortem for tau and amyloid protein tangles—hallmarks of the condition. While these tangles ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the ...

Knight says that the method of transmission that Collinge identified is “extremely unusual,” and there’s no evidence that ...

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

Researchers see VR spaces as a test for spatial memory in people, hoping to look for signs of cognitive decline that are an early sign of Alzheimer’s disease.

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, ...